A revised set of cholesterol guidelines has expanded the number of American adults who qualify for statin therapy by roughly ...

A promising new therapy, the FDA approval of Lipfendra, and updated cholesterol guidelines are expanding treatment options ...

Every day, billions of cells in our body die and are removed as part of normal tissue maintenance. This continuous cleanup ...

Lipoprotein(a) isn't part of a standard lipid panel and is largely driven by genetics. Here's why it's important to get your ...

If your doctor recently prescribed Repatha to help lower your "bad" LDL cholesterol and reduce the risk of heart disease, you ...

Lipfendra, the first once-daily oral PCSK9 inhibitor, was shown to reduce LDL cholesterol by roughly 56% to 60% when combined with statins.

Are you among the millions of us with high cholesterol who don't want to take prescription meds or are wary of statin side ...

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.

Add Yahoo as a preferred source to see more of our stories on Google. Sitting in your doctor's office being told that you have elevated cholesterol can feel like a big blemish on an otherwise good ...

THE cholesterol-lowering drugs statins could be safe to come off at 75, say top heart doctors. A review found that the once-a-day drug, used by millions, may not be necessary for patients over 75 ...

Updated cholesterol guidelines could make more than half of adults ages 30 to 79 in the United States eligible for statins. Here’s what patients should know.

The pill, branded as Lipfendra, is intended to treat patients with hypercholesterolemia, including those with hereditary forms of the disease.